Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0110790A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oxford Glycosciences UK Ltd
Original Assignee
Oxford Glycosciences UK Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oxford Glycosciences UK LtdfiledCriticalOxford Glycosciences UK Ltd
Priority to GB0110790ApriorityCriticalpatent/GB0110790D0/en
Publication of GB0110790D0publicationCriticalpatent/GB0110790D0/en
Priority to EP20020720302prioritypatent/EP1384079A2/en
Priority to PCT/GB2002/002022prioritypatent/WO2002088750A2/en
Priority to AU2002251366Aprioritypatent/AU2002251366A1/en
Priority to US10/700,340prioritypatent/US20040203023A1/en
GB0110790A2001-05-022001-05-02Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of breast cancer
CeasedGB0110790D0
(en)